Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Stomach Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Mesothelioma 1Major Advanced Solid Tumors Other Than Colorectal 1Glioblastoma 1Gastrointestinal Malignancies 1Gastro-enteropancreatic neuroendocrine tumor 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

PM 01183 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Malignancies × PM 01183 × Gastrointestinal × Clear all
NCT05229588 2025-08-15

Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations

HonorHealth Research Institute

Phase 2 Completed
8 enrolled
Gastrointestinal

Gastrointestinal Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡